OCI - Magnet Review licenses

Past New Requirement Updated

Agency
Solicitation expected
Estimated value
$25,000 to $250,000
Set-aside
No set-aside

Forecast facts

Anticipated award
NAICS code
511210 Software Publishers
Points of contact

Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Food and Drug Administration (FDA) is forecasting a new requirement for a cloud or on-premise review platform for Magnet Review licenses, classified under the Software Publishers NAICS code 511210. The estimated solicitation release date is April 1, 2026, with an anticipated contract award date of June 1, 2026. This procurement appears to focus on obtaining a software solution that will support the FDA's review processes.

While specific award values and budget details are not currently available, potential vendors should note the key points of contact are John Salah (john.salah@fda.hhs.gov) from the FDA and an additional contact email (tbd@fda.gov). The contract is not set aside for any specific small business category, suggesting it may be open to a broad range of qualified software providers. Interested companies should prepare to demonstrate their capability to provide a robust review platform that meets the FDA's specific technological and functional requirements.

Forecast text

Cloud or on-premise review platform

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast